Medical News

RSS

Repeal, replace and revise are the new health overhaul buzzwords as congressional power changes hands

Senate Minority Leader Mitch McConnell and 32 other GOP senators officially filed a brief on Thursday in favor of a court case challenging healthcare reform. McConnell filed a 16-page brief in a federal case based in Florida arguing that a key part of the new healthcare law, the requirement that all individuals have health insurance, was unconstitutional.

20 Nov 2010

NEXTERONE Premixed Injection uses CyDex Captisol technology platform

CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.

20 Nov 2010

Study highlights poor outcomes for patients with ESRD admitted over weekend

Patients with end-stage renal disease who are admitted to the hospital during the weekend are at increased risk of death, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition.

20 Nov 2010

GE Healthcare Canada wins ITAC 2010 Company of the Year Award

GE Healthcare Canada, a global leader in information technology, has won the Information Technology Association of Canada's (ITAC) 2010 Company of the Year Award. This award recognizes a distinguished for-profit healthcare IT company that has demonstrated excellence in the Canadian health informatics industry over the past twelve months. GE Healthcare won the award as the solutions provider for several major image exchange projects funded by Canada Health Infoway and eHealth Ontario.

20 Nov 2010

NJISA experts to discuss science, impact and current state of Alzheimer's disease in America

The New Jersey Institute for Successful Aging (NJISA) at the UMDNJ-School of Osteopathic Medicine, one of the country's leading providers of geriatric care, research and education, is making experts available who can discuss the science, impact and current state of Alzheimer's disease in America.

20 Nov 2010

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed the generic manufacturers of propoxyphene-containing products of Xanodyne's decision and requested that they voluntarily remove their products as well.

20 Nov 2010

NexACT technology improves oral delivery of five small molecule drugs

Apricus Biosciences, Inc., today announced data from animal studies showing that the NexACT technology significantly improved the oral delivery of five small molecule drugs tested, with the best improvements up to 20-fold, in terms of improvement in absorption.

20 Nov 2010

Anthem Blue Cross and Blue Shield in Nevada receives award for Our Health Connects Us campaign

Anthem Blue Cross and Blue Shield in Nevada, together with its agency, Deutsch LA, received a 2010 CLIO Healthcare Award for its "Our Health Connects Us" campaign. The bronze level award in the Integrated Campaign category was presented on November 12th at a ceremony in New York City.

20 Nov 2010

Boston Scientific signs definitive agreement to acquire Sadra Medical

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Sadra Medical, Inc., a development-stage company in Los Gatos, California. Sadra is developing the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.

20 Nov 2010

Health industry players offer insights, expectations about overhaul's impact

Republicans made major gains in the midterm election, running vowing to "repeal and replace" the health law passed with solely Democratic votes earlier this year.

20 Nov 2010

Acceleron presents ACE-041 interim results for advanced cancer at EORTC-NCI-AACR Symposium

Acceleron Pharma, Inc., a biopharmaceutical company developing novel protein therapeutics that regulate the growth and development of tissues and cells, including muscle, bone, red blood cells, and vasculature, today announced the presentation of interim results from the first-in-human clinical study of ACE-041 in patients with advanced cancer at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.

20 Nov 2010

Researchers develop medical model for regenerating bladders using stem cells

Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.

20 Nov 2010

Insurers payments to hospitals vary significantly by region

Kaiser Health News staff writer Jordan Rau reports: Adding another piece to the argument that some hospitals are making huge profits from insurers, a new study finds great differences in hospital rates, with San Francisco the most expensive of eight areas that were examined (Rau, 11/18).

20 Nov 2010

Merck wins third FOSAMAX bellwether trial

Merck & Co., Inc. today said a federal court jury in New York found in its favor in the Graves v. Merck case, rejecting the claims of a Florida woman who blamed her dental and jaw related problems on her FOSAMAX use. With today's verdict, Merck has won three of the first four bellwether cases in the FOSAMAX litigation.

20 Nov 2010

Reprogrammed amniotic fluid cells can generate iPS cells

Reprogrammed amniotic fluid cells can generate all types of body cells. High hopes rest on stem cells: one day, they may be used to treat many diseases. To date, embryos are the main source of these cells, but this raises ethical problems. Scientists at the Max Planck Institute for Molecular Genetics in Berlin have now managed to convert amniotic fluid cells into pluripotent stem cells.

20 Nov 2010

No agreement on health cost containment at bipartisan commission

The Obama administration's bipartisan commission studying efforts to reduce the nation's debt remained at odds after three days of closed door meetings - on how to deal with health care costs.

20 Nov 2010

Marshall Edwards receives non-compliance notice from NASDAQ

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Listing Rule 5450(b)(1), the Company's common stock is subject to delisting unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel.

20 Nov 2010

FDA-approved anti-parasite drug blocks Wnt signaling pathway in colon cancer

An old pinworm medicine is a new lead in the search for compounds that block a signaling pathway implicated in colon cancer. The findings, reported by Vanderbilt University Medical Center researchers in the November issue of Nature Chemical Biology, suggest a fresh approach for developing therapeutics that target the pathway.

20 Nov 2010

SuccessEHS Mobile EHR for iPhone helps secure access to critical data

SuccessEHS, a Birmingham-based company specializing in electronic health record (EHR / EMR) and physician practice management software systems, is pleased to announce the launch of Mobile EHR for the iPhone.

20 Nov 2010

States focus on Medicaid budget challenges

Nearly missed in the noise from newly elected politicians vowing to upend the Obama administrations health care reform law was a federal decision allowing California to start implementing it and improve its fiscal situation in the process. On Election Day, California got word it would receive $10 billion in federal Medicaid money to extend coverage to some 500,000 people who are currently uninsured. ...

20 Nov 2010